Used in research and development of therapies targeting amyloid-beta plaques associated with Alzheimer's disease. Binds specifically to amyloid-beta peptides, enabling detection and quantification in biological samples. Supports immunohistochemistry, ELISA, and Western blot applications for studying plaque formation and clearance. Employed in preclinical studies to evaluate efficacy of anti-amyloid treatments and to validate biomarker responses. Also utilized as a reference standard in comparative studies of anti-amyloid antibodies.